Autoimmune disease after autologous hematopoietic stem cell transplantation

被引：36

作者：

Bohgaki, Toshiyuki ^{[1
]}

Atsumi, Tatsuya ^{[1
]}

Koike, Takao ^{[1
]}

机构：

[1] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan

来源：

AUTOIMMUNITY REVIEWS | 2008年 / 7卷 / 03期

关键词：

hematopoietic stem cell transplantation; immune reconstitution; autoimmune disease;

D O I：

10.1016/j.autrev.2007.11.005

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Hematopoietic stem cell transplantation (HSCT) is an effective treatment for refractory autoimmune diseases. The safety and long-term outcome have been also acceptable. Infectious diseases under immune suppressive state after autologous HSCT are common transplantation related complications whereas autoimmune diseases are uncommon. Organ specific autoimmune diseases, such as immune mediated thrombocytopenia and thyroid dysfunction, are the most common after autologous HSCT. Systemic autoimmune diseases can also develop after autologous HSCT in patients with hematological disorders with genetic predisposition to autoimmune diseases. Although the mechanism of autoimmunity after HSCT is not well-known, long-term follow-up is essential in patients with autoimmune diseases treated with autologous HSCT. (C) 2007 Elsevier B.V. All rights reserved.

引用

页码：198 / 203

页数：6

共 32 条

[1] Autoimmune thrombocytopenia following tandem autologous peripheral blood stem cell transplantation for refractory germ cell tumor [J].

Ahmad, I ;

Haider, K ;

Kanthan, R .

BONE MARROW TRANSPLANTATION, 2004, 34 (03) :279-280

[2]

ASHIHARA E, 1993, BONE MARROW TRANSPL, V12, P297

[3] Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation [J].

Au, WY ;

Lie, AKW ;

Kung, AWC ;

Liang, R ;

Hawkins, BR ;

Kwong, YL .

BONE MARROW TRANSPLANTATION, 2005, 35 (04) :383-388

[4] Up regulated expression of tumour necrosis factor α converting enzyme in peripheral monocytes of patients with early systemic sclerosis [J].

Bohgaki, T ;

Amasaki, Y ;

Nishimura, N ;

Bohgaki, M ;

Yamashita, Y ;

Nishio, M ;

Sawada, K ;

Jodo, S ;

Atsumi, T ;

Koike, T .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1165-1173

[5]

BOHGAKI T, IN PRESS N ENGL J ME

[6] Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network [J].

de Kleer, I ;

Vastert, B ;

Klein, M ;

Teklenburg, G ;

Arkesteijn, G ;

Yung, GP ;

Albani, S ;

Kuis, W ;

Wulffraat, N ;

Prakken, B .

BLOOD, 2006, 107 (04) :1696-1702

[7] Multiple autoimmune events after autologous bone marrow transplantation [J].

Deliliers, GL ;

Annaloro, C ;

DellaVolpe, A ;

Oriani, A ;

Pozzoli, E ;

Soligo, D .

BONE MARROW TRANSPLANTATION, 1997, 19 (07) :745-747

[8] A preliminary analysis of the balance between Th1 and Th2 cells after CD34+ cell-selected autologous PBSC transplantation [J].

Endo, T ;

Sato, N ;

Koizumi, K ;

Nishio, M ;

Fujimoto, K ;

Yamamoto, S ;

Sakai, T ;

Bohgaki, T ;

Sawada, K ;

Koike, T .

CYTOTHERAPY, 2004, 6 (04) :337-343

[9]

GONZALEZVICENT M, 2002, HAEMATOLOGICA, P87

[10] Autoimmune thrombocytopenic purpura after autologous stem cell transplantation [J].

Hequet, O ;

Salles, G ;

Ketterer, N ;

Espinouse, D ;

Dumontet, C ;

Thieblemont, C ;

Arnaud, P ;

Bouafia, F ;

Coiffier, B .

BONE MARROW TRANSPLANTATION, 2003, 32 (01) :89-95

← 1 2 3 4 →